MedWatch·Industry news·Business & finance·10d agoItalian owners evoke "mixed feelings" at GNA change in ownership of a major hearing aid manufacturer could reshape product development priorities, brand identity, and supply relationships across the global audiology market.＋Save
PU¶PubMed·Journal article·Hearing aids·11d agoAuditory Skills and Cognitive Functions in Adult Hearing Aid Users: A Cross-Sectional Observational Comparison StudyThis cross-sectional design cannot establish causality; audiologists should note the association between hearing aid use and cognitive function as hypothesis-generating, not as evidence to change counseling practice on cognitive benefits.＋Save
MedWatch·Industry news·Business & finance·11d agoGN launches cost-cutting program: Aims to save USD 31.5 million per yearCost-cutting at a top-five hearing aid manufacturer could signal future changes in product investment, staffing, or supply chains that affect the broader audiology market.＋Save
MedWatch·Financial report·Business & finance·11d agoDanske Bank sees promising outlook for Demant after strong Q1Investor confidence in Demant signals continued R&D and commercial momentum for Oticon products, which may shape future device availability and competition in the hearing aid market.＋Save
Consumer Reports·Blog·Hearing aids·11d agoIt's One of the Best Hearing Aid Features. Many Still Aren't Using It. - Consumer ReportsAudiologists should counsel patients on both Auracast and telecoil options when fitting hearing aids, as infrastructure for each varies by venue and region.＋Save
Hearing Tracker·Financial report·Business & finance·11d agoGN Hearing Delivers 9% Organic Growth as Amplifon Carve-Out Moves ForwardGN Hearing's strong organic growth signals continued investment capacity in hearing aid R&D and distribution, while the Amplifon carve-out may reshape retail clinic ownership dynamics across the sector.＋Save
Hearing Review·Industry news·Hearing aids·11d agoStarkey Expands Omega AI Technology Access for Government ServicesExtending AI-driven hearing technology and dedicated clinical tools to the government/veteran sector could improve fitting workflows and outcomes for a high-need patient population.＋Save
Hearing Review·Industry news·Hearing aids·11d agoOticon Adds Zeal, Intent, and Verit Hearing Aids to VA ContractExpanding VA contract coverage broadens hearing aid access for a large veteran population and signals Oticon's strategic push into the government market segment.＋Save
Hearing Review·Industry news·Hearing aids·11d agoSignia Adds Custom and Instant-Fit IX Models for VA AudiologistsExpanding premium hearing aid options within government health systems broadens access for veterans and underserved populations who rely on federally contracted care.＋Save
MedWatch·Financial report·Business & finance·12d agoDemant delivers strong start to the year on relaunch momentumDemant's relaunch-driven momentum suggests the company is prioritizing portfolio refresh over entirely new platforms, which may affect the pace of clinically meaningful innovation in the near term.＋Save
MedWatch·Industry news·Business & finance·12d agoJyske Bank: Demant’s strong start points to high-end resultsPositive analyst coverage can reflect and reinforce investor confidence in Demant's portfolio strategy, indirectly signaling stability for the audiologists and dispensers who rely on their products.＋Save
MedWatch·Industry news·Business & finance·12d agoDemant CEO teases new launches: "Our platform is very strong"Anticipated Demant product launches could shift competitive dynamics in the premium hearing aid segment and affect dispensing choices for clinicians.＋Save
MedWatch·Financial report·Business & finance·12d agoAmplifon upgrades earnings guidance despite flat revenue – ready for GN mega-mergerThe Amplifon–GN Hearing integration is one of the largest consolidations in the audiology retail and manufacturing sectors, with potential downstream effects on product availability and clinic competition.＋Save
MedWatch·Financial report·Business & finance·12d agoDemant maintains guidance, sees lower-end outcome as "less likely"Demant's confidence in its growth trajectory signals continued investment capacity in hearing technology R&D and market expansion.＋Save
National Acoustic Laboratories (NAL)·Clinical trial·Hearing aids·12d ago· press releaseNAL and EssilorLuxottica’s Nuance Audio publish peer-reviewed clinical trial on Nuance Audio GlassesAudiologists should read the full trial rather than rely on this press release; the involvement of the device manufacturer (EssilorLuxottica) in co-publishing warrants scrutiny of outcome selection and conflict-of-interest disclosures before clinical recommendations are made.＋Save
Hearing Tracker·Product announcement·OTC / consumer·12d agoLexie Launches B3 Hearing Aids Powered by BoseThe continued growth of Bose-powered OTC hearing aids from Lexie signals intensifying competition in the self-fit segment and may shift how some patients with mild-to-moderate hearing loss first access amplification.＋Save
Hearing Review·Industry news·Hearing aids·13d agoOticon Zeal Receives Red Dot Design AwardDesign recognition for paediatric hearing aids signals growing industry attention to child-centred aesthetics and usability, which can influence device acceptance and consistent wear among young users.＋Save
Hearing Tracker·Financial report·Business & finance·13d agoDemant Reports 6% Organic Growth in Q1 2026, Driven by Strong Oticon Zeal LaunchDemant's growth driven by the Oticon Zeal launch signals continued market momentum in premium hearing aids, which may influence product availability, pricing competition, and clinic purchasing decisions.＋Save
Hearing Health Matters·Product announcement·Hearing aids·13d ago· press releaseSignia Expands IX Portfolio for VA Audiologists with Custom and Instant-Fit SolutionsVA, DoD, and IHS audiologists can now fit three additional Signia IX form factors; no clinical evidence is presented, so no change to fitting protocols is warranted beyond awareness of expanded product availability.＋Save
MedWatch·Financial report·Business & finance·13d agoDanske Bank sees potential focus on Demant’s miniature product launch and GN’s sale to Amplifon in interim reportA potential GN–Amplifon deal and Demant's product pipeline are market-shaping events that could alter competitive dynamics, pricing, and product availability across audiology clinics globally.＋Save
PU¶PubMed·Journal article·Hearing aids·2w agoUpdate on Active Middle Ear and Transcutaneous Bone Conduction Hearing SystemsAudiologists and surgeons fitting patients who cannot use conventional hearing aids should review this update, as recent technical advances in both active middle ear implants and transcutaneous bone anchored systems may expand candidacy and performance options.＋Save
PU¶PubMed·Preprint·Hearing aids·2w agoDevelopment and clinical application of a consonant confusion task to evaluate hearing aid benefitThis preprint presents a promising low-cognitive-load speech-in-noise tool for measuring hearing aid benefit, but clinical adoption should await peer-reviewed publication and independent validation.＋Save
PU¶PubMed·Journal article·Hearing aids·2w agoShort-term hearing aid use reduces auditory cortical responses to speech-in-noise listening among older adults with age-related hearing lossShort-term hearing aid use appears to reduce effortful cortical processing of speech-in-noise in older adults, providing neurophysiological support for early fitting; however, the study is preliminary and does not yet warrant a change in fitting protocols beyond reinforcing...＋Save
PU¶PubMed·Journal article·Clinical audiology·2w agoBeyond the audiogram: tone decay as audiological marker for disproportional loss of speech intelligibilityAudiologists should consider adding tone decay testing to their battery for patients whose speech intelligibility is disproportionately poor relative to their pure-tone audiogram, as it may reveal retrocochlear or neural contributions not captured by threshold alone.＋Save
MedWatch·Industry news·Hearing aids·2w agoDemant launches Oticon Zeal through retail channels in the USInclusion of a new hearing aid in the VA contract significantly expands its reach to one of the largest publicly funded hearing healthcare populations in the US.＋Save
MedWatch·Industry news·Business & finance·2w agoEQT has selected banks for a potential IPO of WS AudiologyA potential WS Audiology IPO would be one of the largest events in the hearing industry's financial history, potentially reshaping investment and competitive dynamics across the sector.＋Save
AU★AudiologyOnline·Product announcement·Hearing aids·2w ago· press releaseStarkey Expands Advanced Hearing Technology Access to Government Services with Latest Omega AI EnhancementsBringing AI-enhanced hearing aid features into government service channels could improve hearing care access and device capability for a large, often underserved federal patient population.＋Save
AudiologyOnline·Product announcement·Hearing aids·2w ago· press releaseSignia Expands Integrated Xperience (IX) Portfolio for VA Audiologists with Comprehensive Custom and Instant-Fit SolutionsExtending the IX portfolio into federal procurement broadens fitting flexibility for audiologists serving veterans and other government-covered patients at scale.＋Save
Hearing Tracker·Product announcement·Hearing aids·2w agoSignia Expands IX Portfolio for VA Audiologists with Comprehensive Custom and Instant-Fit SolutionsVA audiologists now have more fitting options within the Signia IX line; no change to clinical protocols is implied.＋Save
